Subscribe to our Newsletters !!
Fermentation is a natural method which is applied
A CO2 incubator is one of the most integral pieces
The human metapneumovirus, more simply referred to
Indegene, a digital-first life sciences commercial
Alembic Pharmaceuticals Limited (Alembic) announce
'Simplicity' seems to be the perfect word to descr
Dear Readers, Welcome to the latest issue of The Magazine
Amidst the number of industries showing interest in practicing sustainability, the pharmaceutical sector is also not lagging behind. The industry is in the process of change as a result of environmental concerns, regulatory needs, and increasing consumer knowledge.
Pharmaceutical production has always been resource-oriented and associated with waste production, energy consumption, and greenhouse gas emission volumes. To confront these barriers is no longer an option – it is a necessity for companies who wish to have a sustainable business model.
Such movements are no longer in the shadows, and gaining popularity among the patients, investors, and all in-between, and help adjust strategy of growth and delivery that fits in the environment scope.
The design of chemical processes and the design of chemical products must be carried out in such a way that the synthesis of volatile and hazardous materials is minimized. For instance, companies are searching for greener methods, such as using enzymatic reactions and renewable solvents. It is also assured that utilizing catalytic processes will relate less waste of resources for a high-quality outcome.
Pharma companies have zero wastes. They also move towards implementing circular economy models. Common practices include recovery of solvents, reuse of water for production, or reduction of packaging materials. Such practices, at best, save on the production costs and at the same time cut down carbon emissions.
Pharmaceutical transitioning to new forms of energy more suitable for the environment is becoming a practice within the sector. Solar, wind, or hydro energy are now very common with the business. For instance, a combination of renewable energy adoption and deployment of energy-conserving architecture allowed some facilities to become carbon-neutral.
Water plays an indispensable role in the pharmaceutical manufacturing process since it is put into use during the production and cleaning phases. Effective water management practices involve, use of rainwater, the application of advanced purification systems, and closed water circuits in the plant that perform water recycling.
Such elements as biodegradable and recyclable materials can be added as opposed to ordinary packaging materials. Furthermore, companies seek to improve their packaging designs with an aim of minimizing the amount of material used while still ensuring that the product remains safe and effective.
Apart from the production floor, sustainability is a consideration that every stakeholder should possess in the supply chain. Generally, due to the stringent nature of standards and sustainability policies being implemented by stakeholders, eco-friendly raw materials and transportation methods are the norm.
While the prospects for what lies ahead with regards sustainability is encouraging, factors affecting sustainability also exists. For instance, high initial purchase costs of green technologies and processes, compliance to regulations, and organizational change are among indications of a slow progress. In contrast, however, the opportunities are enormous. It would be safe to expect companies that take on sustainable practices to gain cost benefits, bolstered regulatory compliance, enhanced brand image and loyalty from green consumers.
The Pharma Green Revolution exemplifies change in paradigm shifting focus on drug development processes that does not compromise on the integrity of the environment while emphasizing on innovation. When these include sustainable methods becomes standard practice; a growing number of the world’s foremost public health issues could be solved by the pharmaceutical industry without detracting the world of life saving medicines that in many cases are essential for millions of people. Today the pharma sector is investing in sustainable practices for a tomorrow that is healthy and sustainable for people and the planet.
